12
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Assessing demographic and socioeconomic factors in patients with advanced colorectal cancer Translated title: Evaluación de factores demográficos y socioeconómicos en pacientes con cáncer colorrectal avanzado

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Abstract Background: The aim of the study was to determine the socioeconomic and demographic factors associated with advanced colorectal cancer (CRC) presentation at our institution. Methods: From January 2009 to January 2018, patients that underwent CRC surgery at our institution were included and retrospectively analyzed. Univariate and multivariate logistic regression were used to determine independent risk factors for presenting with advanced CRC. Results: A total of 277 patients were included, 53.5% presented with advanced CRC. The multivariate analysis identified that living in a rural area (odds ratio [OR] = 5.25; 95% confidence interval [95% CI]: 2.27-12-10; p < 0.001), weight loss (OR = 2.33; 95% CI: 1.35-4.09; p = 0.002), needing emergency surgery (OR = 4.68; 95% CI: 1.25-17.49; p = 0.022), location in the rectum in comparison with colon (OR = 2.66; 95% CI: 1.44-4.91; p = 0.002), and location in the mid rectum (OR = 6.10; 95% CI: 2.31-16.12; p < 0.001) were associated with higher odds of advanced CRC stage at presentation. Conclusions: Patients with lower socioeconomic status, with symptoms, and needing emergency surgery were associated with advanced CRC stage at presentation. Special interventions to improve access to care in this population should be planned to enhance CRC outcomes.

          Translated abstract

          Resumen Introducción: El objetivo del presente estudio es determinar los factores socioeconómicos y demográficos asociados con la presentación de cáncer colorrectal (CCR) en etapas avanzadas en nuestra institución. Métodos: De Enero 2009 a Enero 2018, aquellos pacientes operados por CCR fueron incluidos y analizados de forma retrospectiva. Se realizó análisis de regresión logística para determinar los factores de riesgo independientes para presentar CCR avanzado. Resultados: Se incluyeron un total de 277 pacientes, de los cuales 53.5% se diagnosticaron con CCR avanzado. En el análisis multivariable: vivienda en zona rural (OR = 5.25; 95% CI: 2.27-12-10; p < 0.001), pérdida de peso (OR = 2.33; 95% CI: 1.35-4.09; p = 0.002), necesidad de cirugía de urgencia (OR = 4.68; 95% CI: 1.25-17.49; p = 0.022), tumores en recto (OR = 2.66; 95% CI: 1.44-4.91; p = 0.002), fueron factores asociados a mayor probabilidad de presentación avanzada del CCR. Conclusiones: Pacientes con nivel socioeconómico bajo, aquellos que acuden sintomáticos, y los que requieren de inicio cirugía de urgencia, fueron factores asociados a presentaciones avanzadas de CCR. Se requieren intervenciones especiales para mejorar el acceso a un diagnóstico temprano y oportuno en estos grupos poblacionales.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

          This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

            This document updates the colorectal cancer (CRC) screening recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents the American College of Gastroenterology, the American Gastroenterological Association, and The American Society for Gastrointestinal Endoscopy. CRC screening tests are ranked in 3 tiers based on performance features, costs, and practical considerations. The first-tier tests are colonoscopy every 10 years and annual fecal immunochemical test (FIT). Colonoscopy and FIT are recommended as the cornerstones of screening regardless of how screening is offered. Thus, in a sequential approach based on colonoscopy offered first, FIT should be offered to patients who decline colonoscopy. Colonoscopy and FIT are recommended as tests of choice when multiple options are presented as alternatives. A risk-stratified approach is also appropriate, with FIT screening in populations with an estimated low prevalence of advanced neoplasia and colonoscopy screening in high prevalence populations. The second-tier tests include CT colonography every 5 years, the FIT-fecal DNA test every 3 years, and flexible sigmoidoscopy every 5 to 10 years. These tests are appropriate screening tests, but each has disadvantages relative to the tier 1 tests. Because of limited evidence and current obstacles to use, capsule colonoscopy every 5 years is a third-tier test. We suggest that the Septin9 serum assay (Epigenomics, Seattle, Wash) not be used for screening. Screening should begin at age 50 years in average-risk persons, except in African Americans in whom limited evidence supports screening at 45 years. CRC incidence is rising in persons under age 50, and thorough diagnostic evaluation of young persons with suspected colorectal bleeding is recommended. Discontinuation of screening should be considered when persons up to date with screening, who have prior negative screening (particularly colonoscopy), reach age 75 or have <10 years of life expectancy. Persons without prior screening should be considered for screening up to age 85, depending on age and comorbidities. Persons with a family history of CRC or a documented advanced adenoma in a first-degree relative age <60 years or 2 first-degree relatives with these findings at any age are recommended to undergo screening by colonoscopy every 5 years, beginning 10 years before the age at diagnosis of the youngest affected relative or age 40, whichever is earlier. Persons with a single first-degree relative diagnosed at ≥60 years with CRC or an advanced adenoma can be offered average-risk screening options beginning at age 40 years.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Understanding sociodemographic differences in health--the role of fundamental social causes.

                Bookmark

                Author and article information

                Journal
                cicr
                Cirugía y cirujanos
                Cir. cir.
                Academia Mexicana de Cirugía A.C. (Ciudad de México, Ciudad de México, Mexico )
                0009-7411
                2444-054X
                June 2023
                : 91
                : 3
                : 312-318
                Affiliations
                [1] Mexico City orgnameInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán orgdiv1Department of Colorectal Surgery Mexico
                Article
                S2444-054X2023000300312 S2444-054X(23)09100300312
                10.24875/ciru.22000068
                d37d02d6-02e5-4f9f-a4b2-2cc4ba281e39

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

                History
                : 19 May 2022
                : 26 January 2022
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 29, Pages: 7
                Product

                SciELO Mexico

                Categories
                Original articles

                Advanced colorectal cancer,Cáncer colorrectal,Factores socioeconómicos,Cáncer colorrectal avanzado,Disparidades en acceso a la salud,Colorectal cancer,Socioeconomic factors,Health disparities

                Comments

                Comment on this article